Universität zu Köln

Kapinova, Andrea, Kubatka, Peter, Zubor, Pavol, Golubnitschaja, Olga, Dankova, Zuzana ORCID: 0000-0001-7215-148X, Uramova, Sona, Pilchova, Ivana, Caprnda, Martin, Opatrilova, Radka, Richnavsky, Jan, Kruzliak, Peter and Danko, Jan (2018). The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer. Biomed. Pharmacother., 99. S. 51 - 59. ISSY-LES-MOULINEAUX: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER. ISSN 1950-6007

Full text not available from this repository.

Abstract

Long non-coding RNAs (lncRNAs) are DNA transcripts longer than 200 nucleotides without protein-coding potential. As they are key regulators of gene expression at chromatic, transcriptional and posttranscriptional level, they play important role in various biological and pathological processes. Dysregulation of lncRNAs has been observed in several diseases including cancer. Breast cancer is heterogeneous disease with many molecular subtypes specific in different prognosis and treatment responses. Hypoxia, a common micro-environmental feature of rapidly growing tumour is associated with metastases, recurrences and resistance to therapy. Aberrant expression of hypoxia related lncRNAs significantly correlates with poor outcomes in cancer patients, as the lncRNAs play an important regulatory role in the breast cancer-cell survival. Thus, a better understanding of lncRNAs role in the hypoxic conditions of breast cancer is crucial for precise understanding of the tumorigenesis, disease features and poor clinical outcome, especially in highly aggressive breast cancer subtypes (HER2-positive and triple-negative types). Moreover, lncRNAs may represent tumour marker predicting prognosis and therapeutic targets improving precise and personalized therapy for better patient's survival. In this review, we summarize the recent information on lncRNAs in breast cancer with special focus on the hypoxia-responsive lncRNAs and their potential impact on the prognosis, therapy algorithms and individual outcomes. Presented data helps in better understanding of the specific mechanisms predicting new therapeutic agents and strategies for the pharmacological intervention.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Kapinova, Andrea UNSPECIFIED UNSPECIFIED UNSPECIFIED Kubatka, Peter UNSPECIFIED UNSPECIFIED UNSPECIFIED Zubor, Pavol UNSPECIFIED UNSPECIFIED UNSPECIFIED Golubnitschaja, Olga UNSPECIFIED UNSPECIFIED UNSPECIFIED Dankova, Zuzana UNSPECIFIED orcid.org/0000-0001-7215-148X UNSPECIFIED Uramova, Sona UNSPECIFIED UNSPECIFIED UNSPECIFIED Pilchova, Ivana UNSPECIFIED UNSPECIFIED UNSPECIFIED Caprnda, Martin UNSPECIFIED UNSPECIFIED UNSPECIFIED Opatrilova, Radka UNSPECIFIED UNSPECIFIED UNSPECIFIED Richnavsky, Jan UNSPECIFIED UNSPECIFIED UNSPECIFIED Kruzliak, Peter UNSPECIFIED UNSPECIFIED UNSPECIFIED Danko, Jan UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-194405
DOI:	10.1016/j.biopha.2017.12.104
Journal or Publication Title:	Biomed. Pharmacother.
Volume:	99
Page Range:	S. 51 - 59
Date:	2018
Publisher:	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Place of Publication:	ISSY-LES-MOULINEAUX
ISSN:	1950-6007
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language EPH RECEPTORS; PATIENT STRATIFICATION; CELL-PROLIFERATION; PROGNOSTIC MARKER; FLAMMER SYNDROME; DOWN-REGULATION; BRCA1 PROMOTER; POOR-PROGNOSIS; UP-REGULATION; LNCRNA Multiple languages Medicine, Research & Experimental; Pharmacology & Pharmacy Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/19440